SCHEDULE 13D

Company

Lineage Cell Therapeutics, Inc.

Filed

August 26, 1996

Accession Number

0000909518-96-000285

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →